Teleflex Medical recalls Pleur-evac Thoracic Catheters (DTRC-20S) due to potential sterility issues. These catheters are used in surgical procedures for chest drainage and must be used within 30 days.
“Teleflex Pleur-evac Thoracic Catheters Recall: Potential Sterility Issue.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/64511-teleflex-pleur-evac-thoracic-catheters-recall-potential-sterility-issue. Based on FDA recall #Z-2922-2020 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2922-2020%22&limit=1).
Teleflex Medical Inc. voluntarily recalled Pleur-evac Thoracic Catheters due to a potential sterility issue, according to the Food and Drug Administration on Aug. 7, 2020. The FDA announced the Class II recall under agency number Z-2922-2020.
How to tell if you have it
Brand: Teleflex Medical
Product: Pleur-evac Thoracic Catheters
Catalog No: DTRC-20S
Lot codes: 74K1900074, 74K1901335, 74L1901435, 74M1900809
The hazard
The thoracic catheter is indicated for use in any surgical procedure requiring attachment to a Chest Drainage device and for use less than 30 days. The recall addresses a potential sterility issue with the product.
Context
GovInfoNow's records show Teleflex Medical Inc. has 11 other recalls on record since Oct. 11, 2019. Other recent recalls of similar products include Getinge Thoracic Catheter Recall (Aug. 7, 2026), Medtronic DLP Retrograde Cannula Recall (April 21, 2026) and Stryker BARD Dynamic XT Steerable Catheter Recall (April 10, 2026).
How to tell if you have this one
Check for the catalog number DTRC-20S on the catheter packaging or label. These catheters were sold with serial numbers starting with 74K1900074, 74K1901335, 74L1901435, or 74M1900809.
Brand
Teleflex Medical
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check for Sterility Issues
Inspect the catheter for signs of improper sterilization, such as unusual discoloration or odors.
Where it went and when
Where it was distributed
Distributed in 27 states.
Listed by the agency
Not listed
FDA distribution: “US Distribution of states to: AR AZ CA CO FL GA IA IL IN LA MI MN MS NC NH NV NY OH OK OR PA SD TN TX VA WA WI” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Arizona, Arkansas, California, Colorado, Florida, Georgia, Illinois, Indiana, Iowa, Louisiana, Michigan, Minnesota, Mississippi, Nevada, New Hampshire, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Dakota, Tennessee, Texas, Virginia, Washington, Wisconsin.
Recall timeline
FDA terminated this recall 2.4 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-2922-2020 (August 7, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2922-2020 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.